A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis. A Phase 2, Randomized, Double Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of PF-06826647 in Participants With Moderate to Severe Plaque Psoriasis.

Category & Conditions: Immune System Diseases and Conditions

Medicine: PF-06826647

ClinicalTrials.gov Identifier (NCT): NCT03895372

Protocol ID: C2501004

Print Download

Open Plain Language Summary Result: Click here